Stocks back to record highs as strong earnings and optimism around the Trump trade boost equities, but not everyone’s buying the hype. The concerns from top CEOs that are throwing cold water on the market surge. Plus A subscriber surge from Netflix. The streaming giant posting a big hike in subs, as well as one in prices. The results pushing that name to record highs, and what it means for the streaming wars. Fast Money Disclaimer

Drugmakers in the red, as CMS releases its drugs that are subject to medicare price negotiations. The names getting hit the hardest, and how its impacting the weight loss drug race. Plus Is Intel on the market? M&A rumors helping boost the stock, but who could be the buyer? What a deal could mean for the beaten down chipmaker, and the impact on the tech space. Fast Money Disclaimer